185 related articles for article (PubMed ID: 20546030)
1. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.
Barnes C; Davis A; Furmedge J; Egan B; Donnan L; Monagle P
Haemophilia; 2010 Sep; 16(5):840-1. PubMed ID: 20546030
[No Abstract] [Full Text] [Related]
2. Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis.
Alexander S; Hopewell S; Hunter S; Chouksey A
J Pediatr Hematol Oncol; 2008 Jan; 30(1):93-5. PubMed ID: 18176193
[TBL] [Abstract][Full Text] [Related]
3. The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate.
Chuansumrit A; Moonsup Y; Sirachainan N; Benjaponpitak S; Suebsangad A; Wongwerawattanakoon P
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):208-11. PubMed ID: 18388500
[TBL] [Abstract][Full Text] [Related]
4. Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: is there a role for Rituximab and desensitization therapy?
Gamerman S; Singh AM; Makhija M; Sharathkumar A
Haemophilia; 2013 Nov; 19(6):e382-5. PubMed ID: 23992223
[No Abstract] [Full Text] [Related]
5. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
Chitlur M; Warrier I; Rajpurkar M; Lusher JM
Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
[TBL] [Abstract][Full Text] [Related]
6. Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction.
Curry NS; Misbah SA; Giangrande PL; Keeling DM
Haemophilia; 2007 May; 13(3):328-30. PubMed ID: 17498084
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
8. Eradication of factor IX neutralizing and anaphylactic inhibitors in a patient with severe haemophilia B using cyclophosphamide immune suppression and factor IX desensitization.
Greenmyer JR; Grindeland CJ; Kobrinsky NL
Haemophilia; 2020 Mar; 26(2):e51-e54. PubMed ID: 31961035
[No Abstract] [Full Text] [Related]
9. Identical but different: haemophilia B in monozygotic twins with inhibitor in one brother and subsequent successful immune tolerance induction.
Ranta S; Verbruggen B; Wikström A; Mäkipernaa A
Haemophilia; 2012 Jul; 18(4):e349-51. PubMed ID: 22631443
[No Abstract] [Full Text] [Related]
10. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
11. Immune tolerance induction for a patient with factor IX inhibitors--a case report.
Nagel K; Laudenbach L; Rivard GE; Jardine L; Chan AK; Pai MK
Haemophilia; 2011 Mar; 17(2):315. PubMed ID: 20825499
[No Abstract] [Full Text] [Related]
12. Development of anaphylactic shock in haemophilia B patients with inhibitors.
Warrier I; Lusher JM
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
[TBL] [Abstract][Full Text] [Related]
13. Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A.
Ranta S; Koskinen S; Mäkipernaa A
Haemophilia; 2011 Sep; 17(5):e833-4. PubMed ID: 21624011
[No Abstract] [Full Text] [Related]
14. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
15. Successful immune tolerance induction in two boys with haemophilia B and inhibitory antibodies.
Klukowska A; Laguna P; Waleszkiewicz-Majewska B; Peregud-Pogorzelski J; Kamienska E; Bignell P; Giangrande P
Haemophilia; 2012 May; 18(3):e67-9. PubMed ID: 22531023
[No Abstract] [Full Text] [Related]
16. Inhibitor eradication with rituximab in haemophilia: where do we stand?
Franchini M; Mannucci PM
Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
[TBL] [Abstract][Full Text] [Related]
17. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor.
Holstein K; Schneppenheim R; Schrum J; Bokemeyer C; Langer F
Hamostaseologie; 2014; 34 Suppl 1():S5-8. PubMed ID: 25382771
[TBL] [Abstract][Full Text] [Related]
18. Successful multi-modal immune tolerance induction for factor IX deficiency with inhibitors and allergic reactions.
Kuhn J; Noda C; Massey GV
Haemophilia; 2018 May; 24(3):e133-e136. PubMed ID: 29600592
[No Abstract] [Full Text] [Related]
19. Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure.
Barnes C; Rudzki Z; Ekert H
Haemophilia; 2000 Nov; 6(6):693-5. PubMed ID: 11122398
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
